COMMUNIQUÉS West-GlobeNewswire

California Cannabis Legalization for Adult Use Leads to Record Month for Advantis Corp.

16/01/2018 - 15:15

Newport Beach, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it is filling a record number of Amster-Can orders as a direct result of the legal cannabis law going into [...]

MannKind Corporation to Present at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference

16/01/2018 - 15:00

WESTLAKE VILLAGE, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

MEDIA ADVISORY: Smoking Cessation Experts Coming to Ottawa

16/01/2018 - 15:00

OTTAWA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Tobacco is Canada’s leading cause of preventable disease, disability and death. National and international authorities will be gathering in Ottawa during the 10 th Annual Ottawa [...]

Avis aux médias : Des experts de l’abandon du tabac se rassemblent à Ottawa

16/01/2018 - 15:00

OTTAWA, 16 janv. 2018 (GLOBE NEWSWIRE) -- Le tabagisme demeure la principale cause évitable de maladie, d’invalidité et de décès au Canada. Des experts de partout au monde se rassembleront à Ottawa dans le cadre de la [...]

TRIO Honors Peter Maag with Transplant Innovation Award

16/01/2018 - 15:00

BRISBANE, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value [...]

Avi Pelossof Appointed President and CEO of Immucor

16/01/2018 - 15:00

NORCROSS, Ga., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics and a portfolio company of global alternative asset firm TPG, today announced the [...]

Progressive Care Releases Open Letter to Shareholders

16/01/2018 - 14:45

MIAMI, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

16/01/2018 - 14:45

LAS VEGAS, Jan. 16, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the January 2018 installment obligation under its March 1, 2017 [...]

Skyline Medical Completes Purchase of Preferred Stock in Helomics Corporation

16/01/2018 - 14:30

MINNEAPOLIS, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

Assure Holdings Appoints Peter Csapo as Chief Financial Officer

16/01/2018 - 14:30

PARKER, Colo., Jan. 16, 2018 (GLOBE NEWSWIRE) -- The board of directors of Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has appointed [...]

Acology Canada Markets Heat Up, Big Sales Increases, LPs On Board

16/01/2018 - 14:30

CORONA, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC MARKETS: ACOL ) reports sharp increases in sales throughout Canada as the country edges towards total legalization later this year. Sales of Acology’s [...]

Dyadic International, Inc. Announces Research and Development Collaboration with the Israel Institute for Biological Research (IIBR) to Combat Emerging Diseases & Threats

16/01/2018 - 14:30

JUPITER, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Arbutus Announces Closing of the Second Tranche of a $116M Strategic Investment from Roivant Sciences

16/01/2018 - 14:30

VANCOUVER, British Columbia and WARMINSTER, Pa., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today [...]

Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion

16/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ: PRPO ) has appointed Douglas Sites to the new position of Vice President of Sales where he will be responsible for [...]

Krystal Biotech, Inc. Announces Granting of U.S. Composition of Matter Patent Covering Herpes Simplex Virus (HSV) Vectors and Methods of Using the Same to Treat Skin Diseases

16/01/2018 - 14:00

PITTSBURGH, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS ), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that the United States [...]

HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program

16/01/2018 - 14:00

TUCSON, Ariz., Jan. 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced it has [...]

PetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018

16/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) will announce its financial results for the quarter ended December 31, 2017 on Monday, January 22, 2018 at 8:00 A.M. Eastern [...]

Interface People (IPeople) and Novaseek Research Announce Partnership

16/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Interface People (IPeople), a premiere healthcare integration provider and Novaseek Research, Inc., a health IT for life sciences organization, today announced a [...]

Athenex Receives Positive Feedback from FDA on the Design of Phase III Clinical Trial for Oraxol

16/01/2018 - 14:00

BUFFALO, N.Y., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]